Aminoglycosides (Q72336039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

review article

1 reference

title

Aminoglycosides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

O Lortholary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Tod

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Y Cohen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

O Petitjean

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

761-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

Relation of dosing regimen to aminoglycoside ototoxicity: evaluation of auditory damage in the guinea pig

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Solute permeability of the alveolar capillary barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Pharmacokinetics of anti-infective agents in paediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Aminoglycosides: current role in antimicrobial therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Single daily dosing of amikacin in an in-vitro model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Attenuation of experimental tobramycin nephrotoxicity by ticarcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Once-daily aminoglycoside therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Tobramycin elimination rate change from first to later doses in older cystic fibrosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe gram-negative infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Alterations in the Microbial Flora and in the Incidence of Bacteremia at a University Hospital after Adoption of Amikacin as the Sole Formulary Aminoglycoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Effects of diltiazem on netilmicin-induced nephrotoxicity in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

The post-antibiotic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

A study of amikacin given once versus twice daily in serious infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Aminoglycoside volume of distribution and illness severity in critically ill septic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Predictive performance of equations to estimate creatinine clearance in hospitalized elderly patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Influence of dosage regimen on experimental tobramycin nephrotoxicity. A biochemical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical pharmacokinetics of antibacterial drugs in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Practicalities of once-daily aminoglycoside dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical response and peak concentrations of aminoglycosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Aztreonam compared with gentamicin for treatment of serious urinary tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Determination of a gentamicin loading dose in neonates and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Peak or sustained antibiotic serum levels for optimal tissue penetration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Aminoglycoside Ototoxicity: Influence of Dosage Regimen on Drug Uptake and Correlation between Membrane Binding and some Clinical Features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Aminoglycoside dosing weight correction factors for patients of various body sizes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Single daily dose amikacin in paediatric patients with severe Gram-negative infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Effect of method of administration on extravascular penetration of four antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Kinetics of antimicrobial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Aminoglycoside dosing considerations in intensive care unit patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Clinical pharmacokinetics of newer antibacterial agents in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Therapeutic initiatives for the avoidance of aminoglycoside toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Increased aminoglycoside dosage requirements in hematologic malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930038-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)30038-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7791422%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference